Markets :: Fine Chemicals/Biotech :: Seeds and traits
Evogene files for IPO worth up to $60 million
1:03 PM MDT | September 24, 2013 | Rebecca Coons
Evogene (Rehovot, Israel), a plant genomics firm in which Monsanto and Bayer hold 8.7% and 4.6% stakes, respectively, announced today that it has filed a registration statement with the United States SEC for a proposed initial public offering worth up to $60 million. Additional terms have not been disclosed. According to an F-1 filing, Evogene intends to use approximately half of the proceeds to expedite the commercialization of seed traits and expand its seed traits project portfolio into new traits and crops. The remaining funds will be used to establish...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee